Thursday - March 28, 2024
A Global Study Led by CU Medicine and University of Hong KongMed Discovers a Hepatitis C Virus Drug as Potent Treatment for COVID-19
May 11, 2021
POKFULAM, Hong Kong, May 11 (TNSJou) -- The University of Hong Kong issued the following news release:

A recent global study led by researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) and the LKS Faculty of Medicine at The University of Hong Kong (HKUMed) has discovered a hepatitis C virus drug "simeprevir" as a potent treatment for COVID-19, which can strongly suppress the replication of SARS-CoV-2. The combination of this drug wi . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products